Nodular erythema
Conditions
Interventions
test group:Aconite soup
Control group:Indomethacin
Sponsors
The First Affiliated Hospital of Heilongjiang Chinese Medicine Colledge
Eligibility
Sex/Gender
All
Age
12 Years to 60 Years
Inclusion criteria
Inclusion criteria: Red or purple painful inflammatory nodules, more common in young women, duration of the disease is limited, easy to relapse. Before the onset of history of infection or medication history, skin lesions occur suddenly, bilateral symmetrical subcutaneous nodules, ranging from broad beans to walnuts, the number of 10 or more, conscious pain or tenderness, moderate hardness. Early skin color pink, smooth surface, slightly elevated, a few days later, the skin color turn dark red or red, the surface becomes flat. 3 to 4 weeks after the nodules subsided, leaving temporary pigmentation, nodules never ulceration. Lesions occur in the anterior tibia, also seen in the thigh, upper extensor and neck, rare in the face.
Exclusion criteria
Exclusion criteria: 1. Hard erythema occurred in the calf flexion, often single or a few, lesion more than erythema nodosum, long course, spontaneous rupture, the formation of ulcers, leaving a different degree of healing after healing; 2. Regression fever nodular non-suppurative panniculitis nodular erythema lesions, mainly in the chest, abdomen, stock, buttocks, into a group appear, disappear after leaving atrophy and disc-shaped depression, each attack Have fever, pathological changes to fatty tissue inflammation. Subacute nodular migratory panniculitis is a nodular erythema-like rash that appears in the lower leg. The early course of the disease may occur unilaterally, painlessly, with increased eccentricity, bright red edge and white centrality. Gradually flattened to form plaques, the size of 10 ~ 20cm, ranging in duration from two months to two years, the performance of pigmentation, also known as migratory nodular erythema. Fine believes that subacute nodular migratory panniculitis and chronic nodular erythema may be different clinical types of the same disease, both clinically and pathologically.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate;Tuberculin test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hilar lymph nodes; | — |
Countries
China
Contacts
Public ContactYing Tong
The First Affiliated Hospital of Heilongjiang Chinese Medicine Colledge
Outcome results
None listed